Lipidic nanocapsule drug delivery: Neuronal protection for cochlear implant optimization

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2449-2464

  Meyer, Hartwig ^a,b   Stöver, Timo ^a,c   Fouchet, Florian ^d   Bastiat, Guillaume ^d   Saulnier, Patrick ^d   Bäumer, Wolfgang ^b   Lenarz, Thomas ^a   Scheper, Verena ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITÉ D'ANGERS   (France)

Author keywords

Hearing loss; Inner ear; Nanoparticle; Rolipram; Spiral ganglion cell

Indexed keywords

LIPID NANOCAPSULE; NANOCAPSULE; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; CELL SURVIVAL; CLINICAL EFFECTIVENESS; COCHLEA PROSTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; FEMALE; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NEUROPROTECTION; NONHUMAN; RAT; SPIRAL GANGLION; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; CELL COUNT; CELL SIZE; CELL SURVIVAL; COCHLEA; COCHLEAR IMPLANTATION; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GUINEA PIGS; HEARING LOSS, SENSORINEURAL; HISTOCYTOCHEMISTRY; LIPIDS; NANOCAPSULES; NEURITES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SPIRAL GANGLION; TUMOR NECROSIS FACTOR-ALPHA;

CAVIA;

EID: 84870318901     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29712     Document Type: Article

References (49)

1. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13(1):119-126.
2. Yamane H, Nakai Y, Konishi K. Furosemide-induced alteration of drug pathway to cochlea. Acta Otolaryngol Suppl. 1988;447:28-35.
3. Lenarz T. Cochlear implants: what can be achieved? Am J Otol. 1997;18(Suppl 6):S2-S3.
4. Shibata SB, Budenz CL, Bowling SA, Pfingst BE, Raphael Y. Nerve maintenance and regeneration in the damaged cochlea. Hear Res. 2011;281(1-2):56-64.
5. Altschuler RA, Cho Y, Ylikoski J, Pirvola U, Magal E, Miller JM. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci. 1999;884:305-311.
6. Incesulu A, Nadol JB Jr. Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol. 1998;107(11 Pt 1):906-911.
7. Gillespie LN, Shepherd RK. Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci. 2005;22(9):2123-2133.
8. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci. 1997;15(4-5):631-643.
9. Gillespie LN, Clark GM, Bartlett PF, Marzella PL. BDNF-induced survival of auditory neurons in vivo: cessation of treatment leads to accelerated loss of survival effects. J Neurosci Res. 2003;71(6): 785-790.
10. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, Raphael Y. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res. 2007;228(1-2):180-187.
11. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol. 2000;1(4):315-325.
12. Han JJ, Mhatre AN, Wareing M, et al. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther. 1999;10(11):1867-1873.
13. Suzuki M, Yamasoba T, Suzukawa K, Kaga K. Adenoviral vector gene delivery via the round window membrane in guinea pigs. Neuroreport. 2003;14(15):1951-1955.
14. Husseman J, Raphael Y. Gene therapy in the inner ear using adenovirus vectors. Adv Otorhinolaryngol. 2009;66:37-51.
15. Kho ST, Pettis RM, Mhatre AN, Lalwani AK. Cochlear microinjection and its effects upon auditory function in the guinea pig. Eur Arch Otorhinolaryngol. 2000;257(9):469-472.
16. Pautler M, Brenner S. Nanomedicine: promises and challenges for the future of public health. Int J Nanomedicine. 2010;5:803-809.
17. Scheper V, Wolf M, Scholl M, et al. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond). 2009;4(6):623-635.
18. Newbold C, Richardson R, Huang CQ, Milojevic D, Cowan R, Shepherd R. An in vitro model for investigating impedance changes with cell growth and electrical stimulation: implications for cochlear implants. J Neural Eng. 2004;1(4):218-227.
19. Beaumont E, Whitaker CM, Burke DA, Hetman M, Onifer SM. Effects of rolipram on adult rat oligodendrocytes and functional recovery after contusive cervical spinal cord injury. Neuroscience. 2009;163(4):985-990.
20. Whitaker CM, Beaumont E, Wells MJ, Magnuson DS, Hetman M, Onifer SM. Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury. Neurosci Lett. 2008;438(2):200-204.
21. Zhu J, Mix E, Winblad B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 2001;7(4):387-398.
22. Krause W, Kuhne G, Sauerbrey N. Pharmacokinetics of (2)-rolipram and (a)-rolipram in healthy volunteers. Eur J Clin Pharmacol. 1990;38(1):71-75.
23. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 2002;19(6):875-880.
24. Beduneau A, Saulnier P, Anton N, et al. Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties. Pharmaceutical Res. 2006;23(9):2190-2199.
25. Lefebvre PP, Malgrange B, Staecker H, Moghadass M, Van de Water TR, Moonen G. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport. 1994;5(8): 865-868.
26. Gillespie LN, Clark GM, Bartlett PF, Marzella PL. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport. 2001;12(2):275-279.
27. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223(1):77-92.
28. Agterberg MJ, Versnel H, van Dijk LM, de Groot JC, Klis SF. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J Assoc Res Otolaryngol. 2009;10(3):355-367.
29. Vivero RJ, Joseph DE, Angeli S, et al. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope. 2008;118(11):2028-2035.
30. Versnel H, Agterberg MJ, de Groot JC, Smoorenburg GF, Klis SF. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear Res. 2007;231(1-2):1-12.
31. Wefstaedt P, Scheper V, Lenarz T, Stover T. Brain-derived neurotrophic factor/glial cell line-derived neurotrophic factor survival effects on auditory neurons are not limited by dexamethasone. Neuroreport. 2005;16(18):2011-2014.
32. Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R. Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo). 2008;63(3):321-328.
33. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca23 influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1998;20(4):709-726.
34. Wolf M. 3g-Nanotechnology Based Targeted Drug-Delivery Using the Guinea Pig Inner Ear as a Model Target Organ [thesis]. Hannover, Germany: University of Veterinary Medicine; 2009:91-92.
35. Santini MT, Cametti C, Indovina PL, Morelli G, Donelli G. Polylysine induces changes in membrane electrical properties of K562 cells. J Biomedical Mater Res. 1997;35(2):165-174.
36. Zhang Y, Zhang W, Lobler M, et al. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm. 2011;404(1-2):211-219.
37. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363(25):2434-2443.
38. Vonarbourg A, Passirani C, Desigaux L, et al. The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials. 2009;30(18):3197-3204.
39. Laverty PH, Leskovar A, Breur GJ, et al. A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J Neurotrauma. 2004;21(12):1767-1777.
40. Koob AO, Colby JM, Borgens RB. Behavioral recovery from traumatic brain injury after membrane reconstruction using polyethylene glycol. J Biol Eng. 2008;2:9.
41. Spoendlin H. Factors inducing retrograde degeneration of the cochlear nerve. Ann Otol Rhinol Laryngol Suppl. 1984;112:76-82.
42. Aglah C, Gordon T, Posse de Chaves EI. cAMP promotes neurite outgrowth and extension through protein kinase A but independently of Erk activation in cultured rat motoneurons. Neuropharmacology. 2008;55(1):8-17.
43. Xu N, Engbers J, Khaja S, Xu L, Clark JJ, Hansen MR. Influence of cAMP and protein kinase A on neurite length from spiral ganglion neurons. Hear Res. 2012;283(1-2):33-44.
44. Heystek HC, Thierry AC, Soulard P, Moulon C. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity. Int Immunol. 2003;15(7):827-835.
45. Stoever T, Yagi M, Raphael Y. Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res. 1999;136(1-2):124-130.
46. Mitchell A, Miller JM, Finger PA, Heller JW, Raphael Y, Altschuler RA. Effects of chronic high-rate electrical stimulation on the cochlea and eighth nerve in the deafened guinea pig. Hear Res. 1997;105(1-2): 30-43.
47. Chikar JA, Colesa DJ, Swiderski DL, Di Polo A, Raphael Y, Pfingst BE. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear Res. 2008;245(1-2):24-34.
48. Glueckert R, Bitsche M, Miller JM, et al. Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. J Comp Neurol. 2008;507(4):1602-1621.
49. McGuinness SL, Shepherd RK. Exogenous BDNF rescues rat spiral ganglion neurons in vivo. Otol Neurotol. 2005;26(5):1064-1072.